Please assess the completion status of the following clinical trial:

Trial Title: Phase 3 Study of KHK7580

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Personally submitted written voluntary informed consent to participate in the study~* Stable chronic renal disease treated with peritoneal dialysis for at least 16 weeks before screening~* Intact PTH level of \> 240 pg/ml at screening~Exclusion Criteria:~* Treatment with cinacalcet hydrochloride within 2 weeks before screening;~* Change in dose or dosing regimen of an activated vitamin D drug or its derivative, phosphate binder, or calcium preparation within 2 weeks before screening; or start of treatment with such drugs within 2 weeks before screening;~* Parathyroidectomy and/or parathyroid intervention within 24 weeks before screening;~* Severe heart disease;~* Severe hepatic dysfunction;~* Uncontrolled hypertension and/or diabetes;~* Treatment with an investigational product (drug or medical device) in a clinical study or any study equivalent to clinical study within 12 weeks before screening;~* Primary hyperparathyroidism;~* Other conditions unfit for participation in this study at the discretion of the investigator or subinvestigator.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- KHK7580 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).